1. Company Overview
As a company which aims at becoming the dominant leader in the whole medical devices industry, Baldwin mainly focuses on European and American performance markets. Since Baldwin chooses niche differentiation strategy as its competitive strategy, the potential customers of Baldwin are apparently those who would like to pay high price for premier products. The company has been running extremely stable and profitable in the past 6 years. Baldwin started from 2015, the profit was just cumulating from$2,864in 2015, and in 2021, the amount of cumulative profit increased to $63,819(Capsim 2015). The stock price has a tremendous growth as well, which roughly rise from $31.32 to $78.57during the period of 2015 to 2021 (Capsim 2015).
